Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Toxicity of Very Prolonged Pegasparaginase and Erwinia Asparaginase Courses in Relation to Asparaginase Activity Levels with a Special Focus on Dyslipidemia

Wing H. Tong, MD PhD, Rob Pieters, Hester A. de Groot-Kruseman, PhD, Wim C.J. Hop, PhD, Joachim Boos, MD PhD, Wim J Tissing, MD PhD, Inge M. van der Sluis, MD PhD

Blood (2014) 124 (21): 2256.

https://doi.org/10.1182/blood.V124.21.2256.2256

Published: 2014

Journal Articles

A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia

Wing H. Tong, MD, Rob Pieters, Gertjan Kaspers, MD, PhD, Maroeska D.W.M. te Loo, MD, PhD, Marc Bierings, Cor van den Bos, MD, PhD, Wouter J.W. Kollen, MD, PhD, Wim C.J. Hop, PhD, Joachim Boos, MD, PhD, Mary V. Relling, PharmD, Hans Juergen Kuehnel, MD, Wim J Tissing, MD, PhD, Inge M. van der Sluis, MD, PhD

Blood (2013) 122 (21): 2634.

https://doi.org/10.1182/blood.V122.21.2634.2634

Published: 2013

Journal Articles

Is Recovery of Gonadal function possible in Very Long-Term Adult Male Survivors of Hodgkin's Lymphoma?

Wendy van Dorp, Ivana van der Geest, Joop Laven, Wim C.J. Hop, PhD, Sebastian J.C.M.M. Neggers, MD, PhD, Andrica de Vries, MD, Rob Pieters, MD, PhD, Marry M. van den Heuvel, MD, PhD

Blood (2012) 120 (21): 2065.

https://doi.org/10.1182/blood.V120.21.2065.2065

Published: 2012

Journal Articles

Bone Mineral Density At Diagnosis Determines Fracture Rate in Children Treated According to the DCOG-ALL9 Protocol

Mariel L te Winkel, MD, Rob Pieters, Prof, MD, PhD, Wim C.J. Hop, PhD, Jan C. Roos, Inge M. van der Sluis, MD, PhD, Jos P.M. Bökkerink, MD, PhD, Jan A. Leeuw, MD, Marrie C. A. Bruin, MD, PhD, Wouter J.W. Kollen, MD, PhD, Anjo J.P. Veerman, MD, PhD, Hester A. de Groot-Kruseman, PhD, Marry M. van den Heuvel-Eibrink

Blood (2012) 120 (21): 1469.

https://doi.org/10.1182/blood.V120.21.1469.1469

Published: 2012

Journal Articles

A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia,

Mariël L. te Winkel, MD, Rob Pieters, MD, PhD, Wim C.J. Hop, PhD, Hester A. de Groot-Kruseman, PhD, Maarten H. Lequin, MD, PhD, Inge M. van der Sluis, MD, PhD, Jos P.M. Bökkerink, MD, PhD, Jan A. Leeuw, MD, Marrie C. A. Bruin, MD, PhD, R. Maarten Egeler, MD, PhD, Anjo J.P. Veerman, MD, PhD, Marry M. van den Heuvel-Eibrink, MD, PhD

Blood (2011) 118 (21): 3578.

https://doi.org/10.1182/blood.V118.21.3578.3578

Published: 2011

Journal Articles

The Bone Marrow Niche of Patients with Acute Lymphoblastic Leukemia Produces No Increased Asparagine Levels In Vivo That May Lead to Clinical Asparaginase Resistance

Wing H. Tong, MD, Rob Pieters, MD, PhD, Wim C.J. Hop, PhD, Claudia Lanvers-Kaminsky, PhD, Joachim Boos, MD, PhD, Inge M. van der Sluis, MD, PhD

Blood (2011) 118 (21): 1505.

https://doi.org/10.1182/blood.V118.21.1505.1505

Published: 2011

Journal Articles

Pharmacogenetic Risk Factors for Altered Bone Mineral Density and Body Composition in Pediatric Acute Lymphoblastic Leukemia.

Mariël L. te Winkel, MD, Robert D van Beek, MD, Sabine M.P.F. de Muinck Keizer-Schrama, MD, PhD, André G. Uitterlinden, Prof., Wim C.J. Hop, PhD, Rob Pieters, Prof., M.M. Van Den Heuvel, MD, PhD

Blood (2009) 114 (22): 3071.

https://doi.org/10.1182/blood.V114.22.3071.3071

Published: 2009

Journal Articles

A Randomized Trial Investigating an Exercise Program to Prevent Osteoporosis and Motor Problems during Treatment for Childhood Acute Lymphoblastic Leukemia.

Mariel L. te Winkel, MD, Annelies Hartman, MSc, Robert D. van Beek, MD, Sabine M.P.F. de Muinck Keizer-Schrama, MD., PhD, Han C.G. Kemper, PhD, Wim C.J. Hop, PhD, Marry M. van den Heuvel-Eibrink, MD, PhD, Rob Pieters, MD, PhD

Blood (2008) 112 (11): 912.

https://doi.org/10.1182/blood.V112.11.912.912

Published: 2008

Journal Articles

Coagulation and Fibrinolysis in Children with Acute Lymphoblastic Leukemia; Influences of Dexamethasone and L-Asparaginase.

Inge M. Appel, MD, Wim C.J. Hop, PhD, Rob Pieters, MD, PhD

Blood (2005) 106 (11): 2146.

https://doi.org/10.1182/blood.V106.11.2146.2146

Published: 2005

NARROW

Toxicity of Very Prolonged Pegasparaginase and Erwinia Asparaginase Courses in Relation to Asparaginase Activity Levels with a Special Focus on Dyslipidemia

A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia

Is Recovery of Gonadal function possible in Very Long-Term Adult Male Survivors of Hodgkin's Lymphoma?

Bone Mineral Density At Diagnosis Determines Fracture Rate in Children Treated According to the DCOG-ALL9 Protocol

A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia,

The Bone Marrow Niche of Patients with Acute Lymphoblastic Leukemia Produces No Increased Asparagine Levels In Vivo That May Lead to Clinical Asparaginase Resistance

Pharmacogenetic Risk Factors for Altered Bone Mineral Density and Body Composition in Pediatric Acute Lymphoblastic Leukemia.

A Randomized Trial Investigating an Exercise Program to Prevent Osteoporosis and Motor Problems during Treatment for Childhood Acute Lymphoblastic Leukemia.

Coagulation and Fibrinolysis in Children with Acute Lymphoblastic Leukemia; Influences of Dexamethasone and L-Asparaginase.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only